Amoxicillin–Clavulanic Acid Therapy of Spontaneous Bacterial Peritonitis: A Prospective Study of Twenty–Seven Cases in Cirrhotic Patients
Open Access
- 1 March 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 11 (3) , 360-364
- https://doi.org/10.1002/hep.1840110305
Abstract
Spontaneous bacterial peritonitis in cirrhosis is a serious complication that demands urgent attention. We report here a prospective study of the treatment of 27 episodes of spontaneous bacterial peritonitis in 22 cirrhotic patients with amoxicillin and clavulanic acid. The infection of ascitic fluid was diagnosed by a positive culture plus an ascitic neutrophil count exceeding 75/μl, or by an ascitic neutrophil count exceeding 500/μl. The infection was treated with 1 gm amoxicillin and 0.2 gm clavulanic acid every 6 hr for 14 days. In 17 cases (63%), bacteria were isolated from the ascitic fluid. All the bacteria isolated were sensitive to amoxicillin and clavulanic acid, whereas in five cases they were resistant to amoxicillin alon (Escherichia coli in two cases, Klebsiella pneumoniae in two cases and Bacteroides fragilis in one case). Cure of the infection was achieved in 23 episodes (85%) after 14 days' treatment; 17 patients (63%) were able to leave the hospital. Fourteen of 20 patients (70%) treated for the first episode of infection died within 1 yr: eight from infection, two from gastrointestinal hemorrhage, one from infection and hemorrhage and three from tumors. One patient who had repeated infections underwent liver transplantation and has not had any infectious complications 1.5 yr after surgery. Amoxicillin and clavulanic acid may be an effective first–line therapy for ascitic fluid infection in cirrhosis. Nevertheless, the 1–yr prognosis continues to be grave and the severity of the underlying liver disease remains the most important determinant for survival. (Hepatology 1990;11:360-364.)This publication has 27 references indexed in Scilit:
- Amoxicillin-clavulanate potassium-associated cholestasisGastroenterology, 1989
- Optimization of ascitic fluid culture techniqueGastroenterology, 1988
- Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1986
- Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal floraAntimicrobial Agents and Chemotherapy, 1986
- Nargenicin biosynthesis: Late stage oxidations and absolute configuration.The Journal of Antibiotics, 1985
- 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent .BETA.-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated .BETA.-lactamases.The Journal of Antibiotics, 1982
- In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillinAntimicrobial Agents and Chemotherapy, 1978
- Naturally-occurring .BETA.-lactamase inhibitors with antibacterial activity.The Journal of Antibiotics, 1976
- Spontaneous Bacterial Peritonitis in Cirrhosis: Endemic or Epidemic?Medical Clinics of North America, 1975
- SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSISMedicine, 1971